Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Return on Invested Capital (2016 - 2025)

Historic Return on Invested Capital for Medifast (MED) over the last 15 years, with Q4 2025 value amounting to 0.23%.

  • Medifast's Return on Invested Capital fell 2400.0% to 0.23% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.23%, marking a year-over-year decrease of 2400.0%. This contributed to the annual value of 0.23% for FY2025, which is 2400.0% down from last year.
  • Medifast's Return on Invested Capital amounted to 0.23% in Q4 2025, which was down 2400.0% from 0.0% recorded in Q3 2025.
  • In the past 5 years, Medifast's Return on Invested Capital registered a high of 0.99% during Q3 2022, and its lowest value of 0.23% during Q4 2025.
  • For the 5-year period, Medifast's Return on Invested Capital averaged around 0.49%, with its median value being 0.69% (2023).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first surged by 1800bps in 2022, then crashed by -6200bps in 2024.
  • Medifast's Return on Invested Capital (Quarter) stood at 0.82% in 2021, then rose by 15bps to 0.94% in 2022, then crashed by -48bps to 0.49% in 2023, then crashed by -98bps to 0.01% in 2024, then tumbled by -3132bps to 0.23% in 2025.
  • Its Return on Invested Capital stands at 0.23% for Q4 2025, versus 0.0% for Q3 2025 and 0.0% for Q2 2025.